GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of tried metformin for 12 weeks. here is what happened. — 42 comments in the full submission. View in context.
1.6k
c/t2dglp1·submitted 1 year ago by u/iman_castellanos

tried metformin for 12 weeks. here is what happened.

CGMbranch of 8 comments

The title is the argument: tried metformin for 12 weeks. here is what happened. Here is the rest of it. To save the first four comments: 12 weeks. The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a…

Read the full submission and all 42 comments →

This branch

8 comments, started 1 year ago
u/niels_salinas244 points·1 year ago

Panicked over a first-day sensor reading and rebuilt my week around it. It was the sensor.

replysharereportpermalink
u/graph_it_gary165 points·1 year ago

I would not compare your numbers to that population. Different baseline, different regimen, different trial.

replysharereportpermalink
u/enzo_danquah57 points·1 year ago

a1c can be affected by things that have nothing to do with glucose

replysharereportpermalink
u/chidi_abubakar48 points·1 year ago

dose for glycaemic control is not the same conversation as dose for weight

replysharereportpermalink
u/nadia_norgaard165 points·1 year ago

Yes — the person managing your diabetes is the one to talk to, and this board is explicit about that.

replysharereportpermalink
u/karim_ramos126 points·1 year ago

Yes — the person managing your diabetes is the one to talk to, and this board is explicit about that.

nadia_norgaard is right that the fasting number moves last. Knowing that in advance saves months of worry.

replysharereportpermalink
u/adnan_karlsen30 points·1 year ago·edited

Is that a first-day sensor reading?

replysharereportpermalink
u/niels_salinas42 points·1 year ago

postprandial excursions are where most of the improvement shows up first

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.